
Outlook for Big Pharma Mergers and Acquisitions Discussed
An article explores the current and future prospects for mergers and acquisitions within the Big Pharma industry.
23 stories found

An article explores the current and future prospects for mergers and acquisitions within the Big Pharma industry.
UK has given in to pharma industry lobbying but some EU member states promise to stand firm
Despite ongoing geopolitical headwinds, confidence within the biopharma industry has reportedly reached its highest level in several years, showing resilience amidst global challenges.
The chief executive of JW Therapeutics stated that China's pharmaceutical industry has not been impacted by Beijing's increased scrutiny of sensitive technology deals. This indicates a distinction in how the government views and regulates different high-tech sectors.
China Daily reports on Wuxi's significant role in leading China's push in the biopharmaceutical sector.

Boehringer Ingelheim says pricing regime hinders access to treatments as group touts liver benefits from weight-loss drug

Europe's long-standing dominance in the pharmaceutical sector is reportedly ending, attributed to fragmented capital markets, single-market pricing, uneven reimbursement policies, and the impact of past US policies and China's burgeoning biotech industry.
The pharmaceutical industry is experiencing ongoing changes in leadership, with a continued trend of CEO shake-ups across companies.
The pharmaceutical industry in Bangladesh is on the cusp of a major expansion, signaling a significant leap forward for the sector.

Zsolt Hegedűs has once again appointed a new state secretary to the Ministry of Health from the pharmaceutical industry, with Péter Becságh expected to serve as digital state secretary.

Markus Blocher, patron of Dottikon ES, is concerned about overcapacity in the pharmaceutical industry due to a wave of investments in the American sector, despite having significantly expanded capacities in Aargau himself.
Informa Markets is positioning Bangkok as a central hub for Southeast Asia's pharmaceutical industry by hosting CPHI South East Asia, an event bringing together 400 exhibitors and experts from 70 countries.
Uzbekistan and China are strengthening and expanding their cooperation within the pharmaceutical industry.

A high-ranking official from Switzerland's Federal Office of Public Health publicly accused the pharmaceutical industry of 'rip-offs' and 'threats.' The official questioned the industry's practices, asking if they were trying to 'sell us for fools.'
The chief of Novo Nordisk estimates that the pharmaceutical industry is currently reaching only a fraction of potential customers for weight-loss drugs, indicating a massive untapped market.
The agency is under pressure to tighten oversight of the $42 billion pharma industry, dominated by small manufacturers, after India-made cough syrups have been tied to the deaths of more than 140 children in Africa and Central Asia since 2022, denting its reputation as the “pharmacy of the world”

A fierce confrontation has erupted between the pharmaceutical industry and the government in Germany concerning proposed reforms to drug pricing policies.
Recent changes in leadership among pharmaceutical executives are indicative of broader strategic shifts occurring within the pharma industry.

Markus Isenmann, Sanofi's head of Specialty Care for Austria and Switzerland, discusses the pharmaceutical industry in Austria, bureaucratic hurdles, digital twins, and employee management.
The Norwegian pharmaceutical industry is raising an alarm, holding the Minister of Health and Care Services responsible for patient deaths attributed to delays in receiving necessary medications.
Uzbekistan and China are strengthening their collaboration in the pharmaceutical sector, aiming to enhance drug production, research, and market access between the two countries.
Innovation is providing significant momentum and growth within the pharmaceutical industry.

Shashank Deshpande, CEO of Boehringer Ingelheim, expresses concerns about the state of pharmaceutical research in Germany, emphasizing the need for skilled minds over rare earths, and is undeterred by Trump's pricing policies or the competitive weight-loss drug market.